Article Details
Retrieved on: 2017-12-24 09:30:00
Tags for this article:
Click the tags to see associated articles and topics
Excerpt
<div><b>Vanguard Group</b> Inc. raised its stake in BioMarin Pharmaceutical by 4.7% during the second quarter. <b>Vanguard Group</b> Inc. now owns 14,345,027 shares of the biotechnology company's stock worth $1,302,816,000 after acquiring an additional 642,623 shares in the last quarter. Jennison Associates LLC ...</div>
Article found on:
This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.
Sign UpAlready have an account? Log in here